By studying more than 50,000 variants of a jellyfish gene, researchers at the Centre for Genomic Regulation in Barcelona (Spain) have drawn a detailed picture of how changes in that gene affect its fu...
Read moreEl mayor tamaño relativo del cerebro exige más energía y dependencia, lo cual limita la capacidad de respuesta reproductiva ante los cambios ambientales antropogénicos. Los cambios ambientales cau...
Read moreThe results could form the basis for the development of future interventions in certain heart conditions and myopathies. The study opens new horizons for the study of striated muscle physiology by unv...
Read moreThese results provide new breakthroughs in understanding the neuronal changes related to food-seeking behaviour that may trigger eating disorders, and highlights the relevance of DOR as a possible the...
Read moreLa unidad, coordinada por el Dr. Javier García-Corbacho, es una de las pocas en Europa que obtiene este reconocimiento que permitirá proporcionar fármacos de acceso restringido a los pacientes con ...
Read moreCollaboration boosts development of a fully differentiated inhibitor of the PI3K/Akt/mTOR pathway. ABTL0812 is currently in Phase 2 clinical trials to treat lung and endometrial cancers.
Read moreLa empresa GlaxoSmithKline ha presentado a los investigadores el programa Discovery Partnerships with Academia (DPAC), una iniciativa de innovación abierta que tiene el objetivo de reunir investigado...
Read moreUsing proteome technology, CIMA researchers have established the mechanisms that favor tumor growth and resistance to chemotherapy
Read moreManel Esteller, teacher in the Department of Physiological Sciences II of the Faculty of Medicine, was awarded with the 2015 National Award for Research on May 10, in an institutional event presided b...
Read moreCrescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that it has launched a new web-based portal called myVectra for patients with rheumatoid arthrit...
Read moreLos premios "Business plan aggregator" y las convocatorias de ayudas "Headstart" y "Proof of concept" están dirigidos a ideas de negocio, PYMES, 'spin-off' y 'start-up' El consorcio del EIT Health es...
Read moreEn este estudio, se demuestra que el ligando 1 de la glicoproteína P-selectina (PSGL-1) presente en neutrófilos actúa como un auténtico receptor fagocítico reconociendo la cápsula y la proteína...
Read more